Cytosol-to-lysosome Transport of Free Polymannose-type Oligosaccharides
KINETIC AND SPECIFICITY STUDIES USING RAT LIVER LYSOSOMES*

Agnès Saint-Pol, Patrice Codogno, and Stuart E. H. MooreDagger

From the Unité de Neuroendocrinologie et Biologie Cellulaire Digestives, Institut National de la Santé et de la Recherche Médicale, U410, Faculté de Médecine Xavier Bichat, 16 Rue Henri Huchard, 75018 Paris, France

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In hepatocellular carcinoma HepG2 cells, free polymannose-type oligosaccharides appearing in the cytosol during the biosynthesis and quality control of glycoproteins are rapidly translocated into lysosomes by an as yet poorly defined process (Saint-Pol, A., Bauvy, C., Codogno, P., and Moore, S. E. H. (1997) J. Cell Biol. 136, 45-59). Here, we demonstrate an ATP-dependent association of [2-3H]mannose-labeled Man5GlcNAc with isolated rat liver lysosomes. This association was only observed in the presence of swainsonine, a mannosidase inhibitor, which was required for the protection of sedimentable, but not nonsedimentable, Man5GlcNAc from degradation, indicating that oligosaccharides were transported into lysosomes. Saturable high affinity transport (Kuptake, 22.3 µM, Vmax, 7.1 fmol/min/unit of beta -hexosaminidase) was dependent upon the hydrolysis of ATP but independent of vacuolar H+/ATPase activity. Transport was inhibited strongly by NEM and weakly by vanadate but not by sodium azide, and, in addition, the sugar transport inhibitors phloretin, phloridzin, and cytochalasin B were without effect on transport. Oligosaccharide import did not show absolute specificity but was selective toward partially demannosylated and dephosphorylated oligosaccharides, and, furthermore, inhibition studies revealed that the free reducing GlcNAc residue of the oligosaccharide was of critical importance for its interaction with the transporter. These results demonstrate the presence of a novel lysosomal free oligosaccharide transporter that must work in concert with cytosolic hydrolases in order to clear the cytosol of endoplasmic reticulum-generated free oligosaccharides.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Free polymannose-type oligosaccharides (free OS)1 are a by-product of the biosynthesis of dolichol oligosaccharides (1-3) and the glycosylation of glycoproteins (3, 4). Whereas phosphorylated free OS (Man5GlcNAc2-P) are released from dolichol oligosaccharides on the cytoplasmic face of the ER (5), neutral free OS (Glc3-1Man9-8GlcNAc2) are liberated from oligosaccharide-lipid in the lumen of the ER (1, 6). After deglucosylation, these neutral free OS do not follow the secretory pathway but are routed to the cytosol (7) by an ATP- and calcium-requiring translocation process that can be inhibited by mannose but not by N-acetylglucosamine (8). Glycopepetides (9, 10) and misfolded glycoproteins (11, 12) are also translocated out of the ER into the cytosol, where they can be deglycosylated by an N-glycanase (13, 14), giving rise to further cytosolic free OS.

The rapid appearance of substantial quantities of free OS in the cytosol of cells during the biosynthesis and quality control of glycoproteins suggested that the cytosol must possess elements capable of the disposal of these osmotically active components. In fact, neutral free OS are subject to sequential processing (15-17) by a previously characterized cytosolic endo-H-like activity (18) or chitobiase (15) and cytosolic mannosidase (19-21) to yield a free OS containing five residues of mannose and a single reducing N-acetylglucosamine residue. It has now been demonstrated that this free OS is transferred to lysosomes in order to be degraded (17). The fate of cytosolic phosphorylated free OS is less clear, but since this oligosaccharide possesses an identical configuration of mannose residues to that of the free OS that undergoes cytosol-to-lysosome translocation, it may be transferred directly into the lysosome. The physiological importance of the capture of cytosolic free OS by the lysosome is indicated by the fact that up to 40% of the free OS recovered from the urine of people with the lysosomal storage disease, alpha -mannosidosis, have oligosaccharide structures compatible with their having been generated in the cytosol (22, 23). However, despite the fact that the cytosol-to-lysosome translocation of free OS must represent a vital housekeeping activity in cells engaged in the biosynthesis of glycoproteins, this process remains to be characterized.

Although most molecules destined for degradation in the lysosome arrive by way of a series of vesicular fusion steps after their initial capture, either from the extracellular environment into endocytic vesicles (24) or from within the cell into autophagic vacuoles (25), it has become apparent that the lysosomal membrane itself may be involved in the capture of cytosolic molecules. For instance, cytosolic proteins containing the KFERQ sequence can be translocated into lysosomes by a lysosomally situated translocation machinery comprising both HSC73 and LGP96 molecules (26). In addition, lysosomes may contain specific carriers responsible for the import of cysteine (27) and methotrexate glutamates (28) from the cytosol. In vivo, the cytosol-to-lysosome transfer of free OS was inhibited by agents that reduce cellular ATP levels and by high swainsonine concentrations, which also inhibited the cytosolic demannosylation of free OS (17). However, apart from being able to rule out macroautophagic sequestration as a possible mechanism to account for this phenomenon, little could be inferred about this process.

Here, we demonstrate an ATP-dependent, N-ethylmaleimide-sensitive, saturable import of free OS into isolated rat liver lysosomes. Results are reported to show that the lysosome possesses a novel oligosaccharide importer capable of capturing an array of small polymannose oligosaccharides that possess a reducing GlcNAc residue.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- The following compounds were purchased from Sigma: D-(+)-glucose, D-(+)-mannose, N-acetyl-D-glucosamine, D-(+)-galactose, alpha -L-(-)-fucose, sodium orthovanadate, sodium azide, FITC-dextran (60-70 kDa), valinomycin, phloretin, and phloridzin. Benzyl alpha -D-mannopyranoside, Man(beta 1-4)GlcNAc, Gal(beta 1-4)GlcNAc, and Man(alpha 1-6)(Man(alpha 1-3))Man(alpha 1-6)(Man(alpha 1-3))Man were from Dextra Laboratories Ltd. (Reading, United Kingdom). The alpha -1,2-mannosidase was purchased from Oxford Glycosystems (Abingdon, UK). All chitooligosaccharides were purchased from Seikagaku America, Inc. (Rockville, MD), whereas beta -benzyl chitobioside and alpha -benzyl GlcNAc were from Toronto Research Chemicals (Toronto, Canada). Cytochalasins B and D were from LC Laboratories (Laufelfingen, Switzerland). Concanamycin A (CCM A) was supplied by Dr. J. R. Green (Ciba Geigy Ltd.). The two standard isomers of Man5GlcNAc were supplied by Dr. J-C Michalski (CNRS UMR 111, Lille, France). ATPgamma S, AMP-PNP, and AMP-PCP were from France Biochem, Meudon, France.

Culture and Radiolabeling of Cells-- HepG2 cells (ECACC, Porton Down, UK) were grown as described previously (29). The mutant mouse lymphoma cell line, Thy-1 (provided by Drs. A. Conzelmann and P. Romagnoli, Institut de Biochimie, Université de Lausanne), was cultivated in Dulbecco's modified Eagle's medium (Life Technologies, Inc., Paisley, UK) containing 10% fetal calf serum (Life Technologies) and was metabolically radiolabeled by incubating 30 × 108 cells in 7.5 ml of glucose-free Dulbecco's modified Eagle's medium (Life Technologies) supplemented with 5% dialyzed fetal calf serum, 2 mM glutamine, 5 mM fucose, and 1 mM sodium pyruvate with 1.3 mCi of [2-3H]mannose (30 mCi/mmol) for 4 h in the presence of 10 nM concanamycin A.

Preparation and Purification of Free Oligosaccharides from Metabolically Radiolabeled Lymphoma Cells-- Metabolically radiolabeled neutral free oligosaccharides were prepared from radiolabeled cells as described previously (16), and the resulting [3H]free OS was resolved on plastic thin layer chromatography plates coated with cellulose (Merck), which were developed in pyridine/ethyl acetate/water/acetic acid (5:3:3:1) for either 3 days or for a single day if monosaccharides were to be examined. Resolved components were visualized by autoradiography prior to their elution from the chromatography plates with water and passed over coupled columns of AG 50 (H+ form) and AG 1 (acetate form). Nonretained neutral components were loaded onto charcoal columns as described previously (16), and after washing, free oligosaccharides were eluted from the columns with 30% ethanol. Free oligosaccharide phosphates (2, 30) were isolated from the upper phase of chloroform/methanol/100 mM Tris-HCl, pH 7.4, containing 4 mM MgCl2 (3:2:1) extracts of Thy-1 cells. Material was dried down and passed over coupled columns of AG 50 over AG 1, and, whereas neutral free oligosaccharides were recovered from the run-through and water washes, oligosaccharide phosphates were eluted from the AG 1 with 2 M NaCl. After desalting this material by Biogel P2 chromatography, it was subjected to thin layer chromatography on silica-coated plates that were developed overnight in 1-propanol/acetic acid/water (3:3:2). Four components were resolved, and after digestion with alkaline phosphatase it was found that the slowest migrating component comigrated with Man5GlcNAc2.

Structural Analysis of Free Oligosaccharides-- Free oligosaccharides were treated with 1 unit of jack bean alpha -mannosidase (Sigma) overnight at 37 °C in 40 mM sodium acetate, pH 4.5, or digested overnight at 37 °C with 5 microunits of alpha -1,2-mannosidase (Oxford Glycosystems) in 100 mM sodium acetate buffer, pH 5.0. The digestion products were then desalted as described above, concentrated, and resolved by thin layer chromatography.

Preparation of [3H]Man9-8GlcNAc and the Branched Isomer of [3H]Man5GlcNAc-- Large free oligosaccharides ([3H]Man9-8GlcNAc2) that were generated in permeabilized HepG2 cells and recovered from the membrane-bound compartments (7) were treated with endoglycosidase H to yield [3H]Man9-8GlcNAc. These oligosaccharides were then treated with the alpha -1,2-mannosidase (see above) to yield the branched isomer of [3H]Man5GlcNAc.

Incubation of [3H]Free OS with Permeabilized HepG2 Cells-- HepG2 cells were harvested from cell culture flasks by trypsinization and permeabilized with streptolysin O as described previously (7). Permeabilized cells were then incubated with [3H]free OS and 20 µM swainsonine (SW) in transport buffer (31); 130 mM K+/glutamate, 10 mM NaCl, 2 mM EGTA, 1 mM CaCl2, 2 mM MgCl2, 5 mM HEPES/KOH, (pH 7.3). Incubations were conducted in the presence of ATP and an ATP-regenerating system (5 mM ATP, 3.5 mM creatine phosphate, 25 mg/ml creatine phosphokinase) and 6 mg/ml dialyzed rat liver cytosol.

Preparation of Rat Liver Lysosomes-- Male Wistar rats were sacrificed, and livers were cut into small pieces before being homogenized in 5 volumes of homogenization buffer (250 mM sucrose, 1 mM EDTA, 20 mM HEPES/KOH, pH 7.3) using a tight fitting Dounce apparatus. After centrifuging the homogenate at 600 × g for 10 min, the supernatant was removed and recentrifuged at 18,000 × gav. The resulting mitochondrial/lysosomal pellet was resuspended in homogenization buffer, 5 ml of this suspension was mixed with 3 ml of an 80% Percoll solution (32), and the gradient was subsequently formed by centrifugation for 35 min at 92,570 × gav (32). Material recovered from the bottom third to quarter of the gradient was washed twice with HEPES-buffered sucrose (250 mM sucrose, 20 mM HEPES/KOH, pH 7.3). The final lysosomal pellet was resuspended in 1-1.5 ml of HEPES-buffered sucrose.

The Transport Assay-- Radioactive substrates were dried down into Eppendorf tubes, and the following additions were made, on ice, in the indicated order: 5 µl of water (or, where indicated, test substances); 5 µl of ATP and an ATP-regenerating system (50 mM ATP, 0.5 mg/ml creatine kinase, 70 mM creatine phospate); 20 µl of incubation buffer (350 mM sucrose, 125 mM KCl, 25 mM MgCl2, 20 mM HEPES/KOH, pH 7.3). After mixing, 20 µl of lysosomes were added to make a final volume of 50 µl. Subsequent to further mixing, the tubes were incubated on ice for 10 min prior to being transferred to a water bath at 25 °C. Incubations were terminated by the addition of 1 ml of ice-cold SH, and lysosomes were recovered by centrifugation at 11,600 × gav for 15 min at 4 °C. The resulting supernatant was removed, made 1% with respect to Triton X-100, and kept for beta -hexosaminidase determinations, and the lysosomal pellet was washed with a further 1 ml of SH prior to being solubilized in 1 ml of SH containing 1% Triton X-100. Radioactivity associated with the lysosomal lysate was determined by scintillation counting. In experiments where [3H]free OS transported into lysosomes was to be analyzed, the transport assays were terminated by the addition of 1 ml of ice-cold MH (250 mM mannitol, 20 mM HEPES/KOH, pH 7.3). Lysosomes were also washed, as described above, with MH.

Measurement of Lysosomal pH-- Lysosomal pH was measured as described previously (33). Briefly, rat liver lysosomes were loaded with FITC-dextran in vivo prior to purification as described above. Fluorescence measurements were made by incubating approximately 1 mg of lysosomes under conditions identical to those used for the transport assay (see above).

Protein, Sugar, and Enzymatic Assays-- Lysosomal beta -D-hexosaminidase activity was measured using p-nitrophenyl N-acetylglucosamine as described (34). Protein was measured by the bicinchoninic acid method using a kit purchased from Sigma.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Preparation of Radiolabeled Substrates Suitable for Examining the Cytosol-to-lysosome Transport of Free Oligosaccharides-- In order to develop an in vitro assay for the lysosomal transport of free oligosaccharides, we first sought an abundant source of radiolabeled linear Man5GlcNAc, the component that has been demonstrated to be the major free OS that accumulates in the lysosomes of HepG2 cells treated with the vacuolar ATPase inhibitor CCM A (17). Since the isomeric configuration of the mannose residues in this free OS (17) is known to be the same as that occurring in the Man5GlcNAc2 intermediate that appears during the biosynthesis of dolichol oligosaccharides, we chose to harvest free OS from the mutant mouse lymphoma cell line Thy-1 (35), which, lacking functional dolichol-P-Man synthase, is unable to further mannosylate this oligosaccharide-lipid intermediate (36, 37). Thin layer chromatographic analysis of free OS isolated from Thy-1 cells after metabolic radiolabeling with [2-3H]mannose for 4 h, shown in Fig. 1A, reveals four oligosaccharides (free OSa-d), the largest of which comigrates with authentic Man5GlcNAc. Since it is known that free OS isolated from mammalian cells possess either a di-N-acetylchitobiose moiety or a single residue of N-acetylglucosamine at their reducing termini (1, 4), we wanted to verify that the free OS comigrating with Man5GlcNAc was not Man4GlcNAc2 or a mixture of these two components. This issue was addressed by digesting free OSa with jack bean alpha -mannosidase, and Fig. 1A (lane 6) shows that this treatment yielded mannose and the disaccharide Manbeta 1-4GlcNAc, confirming the parent structure's identity as Man5GlcNAc and not Man4GlcNAc2. Furthermore Fig. 1A (lane 7) reveals that free OSa was sensitive to an alpha -1,2-mannosidase, yielding mannose and a structure that comigrated Man3GlcNAc, confirming that free OSa contains two alpha -1,2-linked mannose residues. Taking into account these results and what is known of the dolichol oligosaccharide biosynthetic pathway in Thy-1 cells (36, 37), free OSa possesses the structure shown in Fig. 1B. Similar structural analyses (results not shown) of free OSb-d indicated that these three oligosaccharides are likely to have the structures indicated in Fig. 1B. Because the mixture of [3H]free OS comprised about 60% Man5GlcNAc, initial transport assays were carried out using the unfractionated oligosaccharide mixture, hereafter referred to as [3H]free OS. In some instances, purified radiolabeled [3H]free OSa was used as substrate and is referred to as [3H]Man5GlcNAc.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 1.   Structural analysis of [3H]free OS isolated from mutant lymphoma Thy-1 cells. A, mutant lymphoma Thy-1 cells were metabolically radiolabeled with [2-3H]mannose as described under "Experimental Procedures." Total [3H]free OS were recovered and analyzed by thin layer chromatography (lane 1), and the four species, labeled a, b, c, and d, were eluted from the plate and rechromatographed to assess their purity (lanes 2, 3, 4, and 5, respectively). The chromatograph was developed for 3 days, and the resolved components were detected by fluorography. The [3H]free OS labeled a was subjected to jack bean alpha -mannosidase (lane 6) or alpha -1,2-mannosidase (lane 7) treatment, and the resulting digestion products were resolved by thin layer chromatography. The chromatograph was developed for 1 day. M, mannose; MGN, Manbeta 1-4GlcNAc; MGN2, Manbeta 1-4GlcNAcbeta 1-4GlcNAc; M3GN, Man3GlcNAc. B, [3H]free OSa-d (A), characterized as shown above, have been assigned the indicated structures, and the amount of each component recovered from a typical radiolabeling experiment is shown. The linkage position of the terminal nonreducing mannose residue of [3H]free OSd was not determined.

Exogenously Applied [3H]Free OS Specifically Associates with the Heavy Membranes of Permeabilized Cells-- Initial experiments were carried out by incubating permeabilized cells with [3H]free OS in the presence of a preparation of dialyzed rat liver cytosol and ATP. SW, a potent inhibitor of lysosomal mannosidases, was also included in assay incubations in order to protect any [3H]free OS that became internalized in lysosomes. Results demonstrated a time-dependent association of [3H]free OS with permeabilized cells that was abolished at 4 °C, stimulated 2-fold by ATP, and stimulated 1.25-fold by the inclusion of 6 mg/ml dialyzed cytosol (results not shown). However, we only observed, while trying to quench the reactions with 200 µM cold Man5GlcNAc, a modest inhibition of the association of [3H]free OS with permeabilized cells, indicating a high nonspecific component to this process. In order to examine this problem in more detail, permeabilized cells were incubated with either [3H]free OS or [3H]inulin in the presence of ATP, SW, and cytosol; washed; and then, after homogenization, fractionated on Percoll density gradients. Fig. 2 demonstrates that whereas both [3H]free OS and [3H]inulin are recovered from regions of the Percoll gradient (fractions 5-11) known to contain light membranes such as those derived from the Golgi apparatus, ER, and endosomal system (17, 32), only [3H]free OS associated with more dense regions of the Percoll gradient containing the lysosomal marker enzyme beta -hexosaminidase. This association was abolished when incubations were quenched with 200 µM unlabeled Man5GlcNAc. These results, although suggesting a specific association of [3H]free OS with lysosomal membranes, indicated that because of the high nonspecific association of radioactive components with permeabilized cells another assay system would be required.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Percoll density gradient fractionation of permeabilized HepG2 cell homogenates. Permeabilized HepG2 cells were incubated with either [3H]free OS (lower panel) or [3H]inulin (upper panel) as described under "Experimental Procedures." Incubations with [3H]free OS were carried out in either the absence (solid circles) or presence (open circles) of 200 µM unlabeled Man5GlcNAc. After terminating the incubations, the permeabilized cells were washed and homogenized. Postnuclear supernatants were mixed with Percoll and centrifuged as described under "Experimental Procedures." The gradients were then separated into 20 fractions, and aliquots were taken for scintillation counting and beta -hexosaminidase (beta -HEX) assay.

[3H]Free OS, but Not [3H]Inulin, Associates with the Membranes of a Lysosome-enriched Particle Fraction in an ATP-dependent Manner-- Percoll-purified rat liver lysosomes were incubated with [3H]free OS or [3H]inulin in the presence or absence of ATP at 37, 30, or 25 °C for the times indicated in Fig. 3. At each time point, the stability of lysosomes was assessed by measuring the beta -hexosaminidase associated with both the pelleted membranes and the supernatant. Results show that at 37 °C there is, in contrast to the situation observed with [3H]inulin, a rapid ATP-dependent association of [3H]free OS with sedimentable membranes. Since there was an approximately 50% loss of beta -hexosaminidase from lysosomes incubated at 37 °C for 80 min, further experiments were carried out at 30 and 25 °C, and as can be seen, incubations performed at the lower temperatures greatly increased the stability of lysosomes over the longer incubation periods. Although these reduced incubation temperatures lead to slower initial rates of association of [3H]free OS with membranes, this association is more sustained and reaches higher maximal levels at the two reduced temperatures. These results demonstrate a time-, temperature-, and ATP-dependent association of [3H]free OS, but not [3H]inulin, with the membranes of a lysosome-enriched particulate fraction. Because this association was ATP- and temperature-dependent and appeared to correlate with the intactness of lysosomes in the lysosomal preparation, it seemed possible that [3H]free OS were being transported into lysosomes.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Association of [3H]free OS with the particulate fraction of a partially pure preparation of lysosomes is time-, temperature-, and ATP-dependent. The Percoll-purified lysosomal fraction was incubated with either [3H]free OS or [3H]inulin at 37, 30, or 25 °C for the indicated times in either the absence (open circle) or presence (closed circle) of ATP. Incubations were terminated by the addition of ice-cold SH, and the particulate fraction was washed twice with this buffer prior to being suspended in SH containing 1% TX-100. Aliquots of this material were taken for scintillation counting (SEDIMENTABLE RADIOACTIVITY). Aliquots of both the particulate fraction and the first wash supernatant were assayed for beta -hexosaminidase activity in order to compute the amount of this enzyme remaining associated with the particulate fraction as a percentage of the total enzyme recovered from both the particulate and supernatant fractions (% SEDIMENTABLE beta -HEX).

[3H]Free OS Transported into Lysosomes-- If free OS are being transported into functional lysosomes, they should be subject to complete catabolism by lysosomal alpha - and beta -mannosidases, yielding mannose and N-acetylglucosamine. Since both of these monosaccharides can be transported out of lysosomes (38, 39), the observed transport of free OS into lysosomes should be greatly increased in the presence of SW, a potent inhibitor of lysosomal mannosidases. If, on the other hand, free OS are simply adsorbed onto the outer surface of membrane-bound organelles, then this process would not be expected to be affected by either the absence or presence of SW. In order to distinguish between these two possibilities, we examined the importance of SW in the assay mixtures, and as shown in Fig. 4A the association of [3H]free OS with lysosomal membranes is greatly enhanced when SW is included in the incubation medium. But does SW increase the association of [3H]free OS with membranes because it protects input [3H]free OS from extralysosomal mannosidases during the transport assay, or because it protects transported substrate from latent (intralysosomal) mannosidases? This question was addressed by looking at the stability of [3H]Man5GlcNAc in both the supernatant and particulate fractions obtained from transport assays that had been conducted in either the absence or presence of SW. Fig. 4B (upper part) shows that [3H]Man5GlcNAc, recovered from the supernatant of transport assays conducted in the absence of SW, is stable, suggesting that SW protects sedimentable [3H]Man5GlcNAc from a latent mannosidase activity. Taken together, these results show that [3H]Man5GlcNAc is transported into functional lysosomes.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   [3H]free OS is transported into lysosomes. A, lysosomes were incubated with [3H]free OS at 25 °C for 1 h in the presence of ATP and increasing concentrations of swainsonine. Radioactivity associated with the particulate fraction (solid circles) was assayed as described for Fig. 3 (SEDIMENTABLE RADIOACTIVITY). The amount of sedimentable beta -hexosaminidase has been expressed as a percentage of that occurring in the absence of swainsonine. B, after incubation of lysosomes with [3H]Man5GlcNAc, radioactive components were recovered from the supernatant (top panel), and particulate (bottom panel) fractions derived from incubations conducted in either the absence or presence of 100 µM swainsonine and analyzed by thin layer chromatography.

Lysosomal Import of [3H]Man5GlcNAc Displays Michaelis-Menten-type Kinetics-- Since lysosomes are not permeable to the disaccharide sucrose (40), this organelle would not be expected to be permeable to larger free OS. Accordingly, the lysosomal membrane should possess free OS transport machinery showing both specificity and saturability. The saturability of the transport process was examined by incubating lysosomes with increasing concentrations of [3H]Man5GlcNAc (1 × 105 cpm/nmol). These incubations were performed at 30 °C for 10 min, conditions where transport was observed to be linear (see Fig. 3). Results demonstrate (Fig. 5) that the ATP-dependent transport of [3H]Man5GlcNAc into lysosomes shows saturability, and typical Michaelis-Menten saturation kinetics (Km, 22.3 µM; Vmax, 7.1 fmol/min/unit of beta -hexosaminidase) were observed.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Kinetics of ATP-dependent [3H]free OS transport into lysosomes. Upper panel, lysosomes were incubated either in the absence or presence of ATP at 30 °C for 10 min with increasing concentrations of [3H]Man5GlcNAc (specific activity 1 × 105 cpm/nmol). After terminating the incubations and washing the particulate fraction twice, aliquots of the lysed lysosomal pellet were taken for scintillation counting and beta -hexosaminidase assay as described under "Experimental Procedures." The saturable transport component (curve without experimental points) was computed by subtracting the ATP-independent sedimentable radioactivity from the ATP-dependent sedimentable radioactivity. Lower panel, double reciprocal analysis of the saturable, ATP-dependent, transport component.

Lysosomal Free OS Transport Shows Selectivity toward Trimmed, Nonphosphorylated Free OS-- In order to examine the selectivity of free OS transport into isolated rat liver lysosomes, we conducted transport assays using the free OS that are generated physiologically by the ER during glycoprotein biosynthesis. First, phosphorylated Man5GlcNAc2 (Man5GlcNAc2-P; see Fig. 6A) released from dolichol-PP-Man5GlcNAc2 on the cytosolic face of the ER (5), was tested, and as can be seen in Fig. 6A we were unable to detect lysosomal sequestration of this compound unless it had been previously treated with alkaline phosphatase, indicating that the specific activity of our preparation of phosphorylated [3H]Man5 GlcNAc2 was sufficiently high to observe transport. In addition, these results show that free OS terminating with a reducing di-N-acetylchitobiose moiety can also be transported into rat liver lysosomes. Second, we were not able to detect lysosomal import of the large free polymannose oligosaccharides ([3H]Man9-8GlcNAc2; see Fig. 6A) that are transported out of the ER during glycoprotein biosynthesis (7, 8). Furthermore, treatment of these components with endoglycosidase H, generating [3H]Man9-8GlcNAc, did not affect their ability to be sequestered by lysosomes. However, treatment of this free OS preparation with endoglycosidase H and an alpha -1,2-mannosidase generated a branched isomer of [3H]Man5 GlcNAc, which was found to be transport-competent, indicating that the specific activity of the parent [3H]Man9-8GlcNAc2 was sufficient in order to observe lysosomal import. The above result indicated that free OS uptake is not dependent upon the alpha -1,2-linked mannoses of the free OS, suggesting that the Man4-3GlcNAc structures shown in Fig. 1 may also be transport substrates. This is confirmed in Fig. 6B, where it is shown that these oligosaccharides are good transport substrates. In summary, these results demonstrate that the free OS and phosphorylated free OS that are generated by the ER during glycoprotein biosynthesis are not efficiently imported into lysosomes unless they are processed by cytosolic glycosidases and/or phosphatases.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 6.   Phosphorylated and fully mannosylated free oligosaccharides are poor substrates for lysosomal import. A, standard transport assays were conducted using either an aliquot of [3H]Man5GlcNAc2-P (structure on upper left) or an aliquot of the same preparation treated with alkaline phosphatase (Alk. phosp'ase) as substrates. In a separate experiment, transport assays were conducted on aliquots of a preparation of large free polymannose-type oligosaccharides ([3H]Man9-8GlcNAc2; structure on upper right), which were either untreated or digested with endoglycosidase H (Endo H) alone to yield [3H]Man9-8GlcNAc or endoglycosidase H and an alpha -1,2-mannosidase (the dotted lines in the structure on upper right indicate the alpha -1,2 linkages) to yield the branched isomer of [3H]Man5GlcNAc. B, 50,000 cpm of the indicated oligosaccharides were incubated with lysosomes under the standard assay conditions for 0, 5, and 10 min. The oligosaccharide structures and their abbreviations are defined in the legend to Fig. 1.

The Cytosol-to-lysosome Free OS Transporter Recognizes a Reducing N-Acetylglucosamine-containing Sugar Motif-- In order to compare lysosomal free OS transport with other sugar transport processes, we wanted to characterize the sugar motif that is recognized by the lysosomal transporter. Knowing that the ER-to-cytosol transport of free OS is inhibited by mannose and various mannosides (8), we conducted lysosomal transport assays in the presence of several commonly occurring monosaccharides. Fig. 7A shows that when lysosomes are incubated with [3H]Man5GlcNAc in the presence 50 mM glucose, galactose, mannose, fucose, or N-acetylglucosamine (GlcNAc), each provokes a 15% loss of beta -hexosaminidase from lysosomes; in contrast, whereas glucose, galactose, mannose, and fucose cause about 20% transport inhibition, GlcNAc completely abolishes [3H]Man5GlcNAc transport. Furthermore, dose-response curves to GlcNAc, N-acetylgalactosamine, and N-acetylmannosamine (see Table I), show that GlcNAc (IC50, 1.2 mM) is 20 times more potent than GalNAc (IC50, 26 mM) at inhibiting [3H]Man5GlcNAc transport, whereas ManNAc has little inhibitory activity. Since streptozotocin and glucosamine have reduced [3H]Man5GlcNAc transport inhibitory potencies when compared with that of GlcNAc, it is clear that the N-acetyl group of the GlcNAc residue plays an important role in oligosaccharide recognition by the transport machinery (Table I). Fig. 7B and Table I demonstrate two important structural features required for increased inhibitory potency of sugars. First, the compound must possess an intact or free reducing GlcNAc residue; accordingly, N-acetylglucosaminitol and alpha -benzyl GlcNAc have reduced inhibitory capacities when compared with that of GlcNAc, and di-N-acetylchitobiitol and beta -benzyl di-N-acetylchitobioside are much less potent than di-N-acetylchitobiose at inhibiting [3H]Man5GlcNAc transport into lysosomes. Second, substituting the reducing GlcNAc residue with Gal, Man, or GlcNAc at position 4 results in 7-, 19-, and 240-fold increases, respectively, in the inhibitory potency of the GlcNAc, indicating that although a reducing GlcNAc moitey is the most important determinant of the structural motif recognized by the transport machinery, a second sugar linked beta 1-4 to the GlcNAc greatly enhances the interaction of the substrate with the transporter. In addition, Table I shows that the linear isomer of Man5GlcNAc is about 2-fold more efficient at inhibiting [3H]Man5GlcNAc transport than is Manbeta 1-4GlcNAc, indicating that the transporter recognizes not only this disaccharide unit but also other more distal mannose residues. Finally, Table I shows that whereas the branched isomer of Man5GlcNAc (see Fig. 6) interacts with the transporter less efficiently than its linear counterpart, the same oligosaccharide devoid of its reducing GlcNAc residue had no effect on [3H]Man5GlcNAc transport over the concentration range tested. In another type of experiment we treated [3H]Man5GlcNAc with sodium borohydride and found that the reduced oligosaccharide was no longer a substrate for lysosomal import (results not shown). Taken together with the transport specificity studies shown in Fig. 6 and the transport inhibition experiments summarized in Table I, these results demonstrate that the lysosomal transporter recognizes predominantly the reducing Manbeta 1-4GlcNAc disaccharide moiety of free OS.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7.   Lysosomal [3H]Man5GlcNAc transport is inhibited by N-acetylglucosamine and various N-acetylglucosamine-containing disaccharides. A, standard transport incubations were conducted in the presence of the indicated monosaccharides (50 mM), and the percentage of inhibition of [3H]Man5GlcNAc transport was evaluated as described under "Experimental Procedures." The percentage of sedimentable beta -hexosaminidase present at the end of each incubation was evaluated by performing beta -hexosaminidase assays on both the pellet and supernatant fractions and comparing this value to that obtained in incubations performed in the presence of ATP alone (100% sedimentable beta -hexosaminidase). B, standard transport assays were performed in the presence of increasing amounts of GlcNAc (GN), Manbeta 1-4GlcNAc (Man-GN), Galbeta 1-4GlcNAc (Gal-GN), and GlcNAcbeta 1-4GlcNAc (GN-GN).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Inhibition of [3H]Man5GlcNAc transport into lysosomes by N-acetylglucosamine and related saccharides

Lysosomal Free Oligosaccharide Transport Is Not Blocked by Various Commonly Used Sugar Transport Inhibitors-- The selectivity of the lysosomal free OS transport process suggested that it is carried out by a novel transporter distinct from the hexose and GlcNAc/GalNAc transporters already described in mammalian cells. In order to gain more information on the characteristics of this transporter, we conducted transport assays in the presence of various classical sugar transport inhibitors. Cytochalasin B, unlike its close relative cytochalasin D, inhibits the plasma membrane glucose carrier (41), the lysosomal hexose carrier (42), and also the lysosomal N-acetylhexosamine transporter (38). Phloretin and phloridzin inhibit the plasma membrane glucose carrier and the Na+-dependent active hexose transporter, respectively (41, 43), whereas verapamil is an excellent substrate for the multidrug resistance protein (44). However, as can be seen from the upper portion of Table II, none of the above compounds possess significant inhibitory action toward [3H]free OS transport into lysosomes.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effects of different transporter inhibitors on the import of free oligosaccharides into lysosomes

[3H]Free OS Transport into Isolated Rat Lysosomes Requires the Hydrolysis of ATP and Is NEM-sensitive but Independent of the Ability of the Vacuolar ATPase to Acidify Lysosomes-- In order to further characterize the import of free OS into isolated rat liver lysosomes, we have investigated the role of ATP in this process using the in vitro transport assay. First, we tested whether free OS transport into isolated rat liver lysosomes required the hydrolysis of ATP, and as shown in Fig. 8A the nonhydrolyzable ATP analogs ATPgamma S, AMP-PNP, and AMP-PCP were not efficient promoters of free OS transport. We went on to verify that, under our transport assay conditions, ATP hydrolysis leads to acidification of lysosomes, and, as shown in Fig. 8B, the addition of ATP to FITC-dextran-loaded lysosomes led to a carbonyl cyanide m-chlorophenylhydrazone-reversible quenching of fluorescence, indicating lysosomal acidification (33); furthermore, this acidification was inhibited by CCM A and NEM, two inhibitors of the vacuolar ATPase (45, 46). Next, we examined the nature of the ATPase activity responsible for the coupling of ATP hydrolysis to lysosomal free OS import by testing a panel of well known ATPase inhibitors in the transport assay. Table II shows that whereas [3H]free OS transport is sensitive NEM, a nonspecific thiol-reactive ATPase inhibitor, the specific vacuolar ATPase inhibitor, CCM A, is without effect. Furthermore, Table II demonstrates that whereas vanadate, a known inhibitor of P-type ATPases (47) and the multidrug-resistant glycoprotein (44), weakly inhibits free OS transport into lysosomes, sodium azide, a potent inhibitor of the mitochondrial F0-F1-type ATPase (45), was able to significantly potentiate [3H]free OS transport into lysosomes. This effect may be due to the latter compound's ability to inhibit phosphatases in the incubation mixtures, thereby protecting the ATP and ADP during assays.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   ATP hydrolysis leads to both free OS transport and activation of the proton pumping ATPase. A, transport assays were carried out in the presence of 5 mM ATP or the nonhydrolyzable ATP analogues ATPgamma S, AMP-PNP, and AMP-PCP (all 5 mM). The transport of [3H]free OS observed in the presence of 5 mM ATP has been set at 100%. Lysosome disruption was monitored as described in the legend to Fig. 6, and the percentage of sedimentable beta -hexosaminidase observed in the presence of 5 mM ATP has been set at 100%. B, FITC-dextran-loaded lysosomes were prepared as described under "Experimental Procedures" and incubated under standard transport assay conditions at room temperature (22 °C) in a stirred cuvette. Fluorescence recordings were initiated, and, after stabilization of the base line, water (upper trace), NEM (1 mM final concentration, middle trace), or CCM A (100 nM final concentration, lower trace) was added prior to the addition of ATP (6.25 mM final concentration). After observing the effect of ATP, the proton ionophore carbonyl cyanide m-chlorophenylhydrazone was added (25 µM final). A downward deflection of the trace is a measure of the fluorescence quenching caused by lysosomal acidification, whereas an upward deflection represents an alkalinization of the lysosomal interior.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Initial transport experiments, carried out using permeabilized HepG2 cells (Fig. 2), suggested that lysosomal membranes have the ability to interact with [3H]free OS and led us to test the ability of partially purified rat liver lysosomes to sequester these components. Our lysosome purification procedure led to a 30-40-fold enrichment of beta -hexosaminidase activity over that observed in the initial homogenate (results not shown), and in general, greater than 90% of the beta -hexosaminidase was found to be sedimentable (see percentage of sedimentable beta -hexosaminidase at t = 0 in Fig. 3). In addition, we were able to show, as have others (33), that lysosomes remain acidic during their purification. Thus, the addition of either the proton ionophore, carbonyl cyanide m-chlorophenylhydrazone, or valinomycin, a potassium ionophore, individually to FITC-dextran-loaded lysosomes resulted in modest alkalinizations, whereas the addition of both reagents together induced a rapid and substantial alkalinization of lysosomes (results not shown), indicating that the lysosomal membranes in our lysosome preparation had low permeabilities to both hydrogen and potassium ions and were more acid than the surrounding incubation medium (33).

Much evidence indicates that not only do free OS associate with the lysosomes in the lysosome-enriched preparation, but they are also transported into functional lysosomes. First, there appeared to be a correlation between association of free OS with the membranes of the lysosomal preparation and the stability of the lysosomes in this preparation (see Fig. 3). Second, we found that association of free OS with the particulate fraction of the lysosomal preparation was greatly enhanced by the addition of low concentrations of SW to the incubation mixtures. As SW had no effect on the stability of free OS not associated with membranes, we were able to conclude that SW is protecting sedimentable free OS from latent mannosidase activities. Since the lysosome is the only known organelle possessing enzymes capable of completely hydrolyzing free OS into their constituent monosaccharides, we conclude that free OS are being transported into the lysosomes of our lysosome-enriched fraction and not into other contaminating organelles.

The Lysosomal Free OS Transporter Displays a Unique Specificity That Distinguishes It from the ER-to-cytosol Free OS Transporter-- Our results show that large polymannose structures (Man9-8GlcNAc2), irrespective of whether they are free or linked to peptide, protein, or lipid, interact poorly with the transporter. On the other hand, less mannosylated free OS (Man5-3GlcNAc) were found to be transport substrates, indicating that the peripheral mannose residues of the larger structures are inhibitory to transport. Inhibition studies with mono- and disaccharides (Fig. 7 and Table I) revealed that the transporter binds predominantly to the GlcNAc-containing reducing terminus of the free OS and that a second sugar linked beta -1,4 to the reducing GlcNAc enhances affinity. Furthermore, since linear Man5GlcNAc was better at quenching transport than Manbeta 1-4GlcNAc and [3H]Man3GlcNAc appeared to be a better transport substrate than [3H]Man5GlcNAc, either or both of the mannosyl residues linked alpha -1,3 and alpha -1,6 to the Manbeta 1-4-GlcNAc core must also add to the binding affinity. To summarize, a possible hypothesis for the interaction of free OS with the lysosomal transporter is that small free oligosaccharides are able to enter a pocket in the transport molecule and, once inside, bind tightly to the transporter via their reducing termini. More fully mannosylated or branched free oligosaccharides, although possessing the same high affinity binding motif, are sterically impeded from entering the pocket and are therefore neither good substrates for transport nor good transport inhibitors. Surprisingly, we noted that the most potent inhibitors of [3H]free OS import into lysosomes were small chitooligosaccharides containing 2-4 residues of GlcNAc, and the parallelism of the dose-response curves shown in Fig. 7B suggests that GlcNAc, chitobiose, N-acetyllactosamine, and Manbeta 1-4-GlcNAc inhibit free OS transport by a common mechanism. These results suggest that the high affinity binding pocket of the lysosomal free OS transporter may be similar to those of many chitin-binding proteins and chitinases that possess a cysteine and glycine-rich structural motif known as the hevein domain (48). Lectins possessing this structural motif such as wheat germ agglutinin (49) and Urtica dioca agglutinin (50) bind GlcNAc and small chitooligosaccharides in the following order: chitotetraose >=  chitotriose > chitobiose >> GlcNAc. These observations led investigators to propose that the sugar binding sites of such lectins comprise three closely situated subsites (49, 50). However, our transport inhibition studies (Table I) demonstrate that chitooligosaccharides inhibit [3H]free OS transport with the following order of potency: chitotetraose >=  chitotriose >=  chitobiose >> GlcNAc, suggesting that the free OS binding pocket of the lysosomal transporter may possess only two high affinity sugar binding sites. It is also noteworthy that both alpha - and beta -N-acetylglucosaminisides bind more efficiently to wheat germ agglutinin than does GlcNAc, whereas our transport inhibition studies show that blocking of the reducing terminus of GlcNAc and di-N-acetylchitobiose with alpha - and beta -benzyl moieties, respectively, greatly reduced their capacities to quench free OS transport (Table I), indicating further differences between the oligosaccharide binding domain of the lysosomal free OS transporter and that of hevein-type lectins. At present, it is not known whether or not the lysosomal free OS transporter can import chitooligosaccharides into lysosomes, but it is noteworthy that similar structures not only exist in invertebrates and fungi but may exist in vertebrates and play a role in their development (51, 52).

The ER-to-cytosol transport of large free polymannose-type OS can be inhibited by mannose (IC50, 4.9 mM) and mannosides (benzyl mannoside, IC50, 0.8 mM) but neither by N-acetylglucosamine (50 mM) nor di-N-acetylchitobiose (10 mM) (8), indicating that the ER and lysosomal transporters recognize different structural motifs of free OS. Whereas the interaction of large free polymannose-type oligosaccharides with the ER-to-cytosol transport apparatus has similarities to ER-situated N-glycan-lectin/enzyme interactions (calcium dependence/inhibition by mannosides; see Ref. 8), the interaction of free OS with the lysosomal transporter bears similarities to the interactions between free OS and cytosolic glycosidases. Accordingly, the cytosolic chitobiase (15) by definition interacts with the reducing di-N-acetylchitobiose moiety of free OS, but more surprisingly, the cytosolic mannosidase has been found to act only on free OS bearing a single GlcNAc residue at their reducing termini (20). Therefore, these two enzymes and the cytosol-to-lysosome free OS transporter interact with free OS in a manner that involves surveillance of the reducing terminus of the oligosaccharide. Perhaps this system has developed to promote an ordered processing of free OS in the cytosol and to ensure that glycoproteins, glycopeptides, and dolichol oligosaccharides do not interfere with the sequestration of free OS by lysosomes.

A Novel Transporter Is Responsible for the Import of Free Oligosaccharides into Lysosomes-- How do the kinetic characteristics of lysosomal free OS transport compare with those of other lysosomal and plasma membrane sugar transporters? Here we observed that lysosomal free OS sequestration was temperature-dependent and displayed a Q10 of about 2.5 (calculated from the ATP-dependent transport observed after 5-min incubations at 37, 30, and 25 °C; see Fig. 3), which is similar to other lysosomal sugar transport systems (N-acetylhexosamines (38), Q10 = 2.3; sialic acid (53), Q10 = 2.4). We were unable to detect saturable free OS transport into lysosomes unless ATP was included in the incubation mixtures; furthermore, we show that free OS transport into lysosomes is critically dependent upon ATP hydrolysis, yet independent of a functional lysosomal proton pump. In contrast, other mammalian lysosomal transporters influenced by ATP such as those described for sialic acid and sulfate show saturability in the absence of ATP and have been shown to be stimulated only about 2-fold by the addition of ATP (39, 54). The ATP-dependent transport of free OS into lysosomes showed Michaelis-Menten-type saturation kinetics displaying a Kuptake of 22.3 µM. This value is significantly lower than the Kuptake values obtained for lysosomal hexose (Glc, 75-90 mM; Man, 50-75 mM (42)), N-acetylhexosamine (GlcNAc, 4.4 mM, GalNAc, 4.4 mM (38)), and sialic acid (0.24 mM (39)) carriers. Our Kuptake value must be considered as an approximation, since 10-min incubations at 30 °C represent the limit of the linearity of the initial transport rate; however, the time chosen was a compromise, since shorter incubation times would have led to very low levels of radioactivity becoming associated with lysosomes. Nevertheless, another cytosolic activity implicated in the clearance of ER-generated free OS from the cytosol, the neutral cytosolic endoglycosidase H-like activity, was recently found to have a Km value of 25 µM for pyridylaminated Man6GlcNAc2 (55). Here, we demonstrate that free OS import into lysosomes was sensitive to NEM, a thiol-reactive drug that inhibits many ATPases (33, 56). In contrast, free OS import into lysosomes was only weakly inhibited by vanadate, an inhibitor of P-type ATPases (47) and not at all by the F0-F1 type ATPase inhibitor sodium azide (45). Furthermore, we were unable to demonstrate inhibition of lysosomal free OS import by other well known sugar transporters such as cytochalasin B, phloretin, and phloridzin. Taken together with the unique selectivity of the transport process, these results demonstrate that the sequestration of free OS into lysosomes is accomplished by a novel transporter. The ability of lysosomes to continually clear ER-generated free polymannose-type oligosaccharides from the cytosol indicates that this free OS transporter must be considered an important housekeeping activity of cells engaged in the biosynthesis of glycoproteins.

    ACKNOWLEDGEMENTS

We thank Drs. J. R. Green, J-C. Michalski, A. Conzelmann, and P. Romagnoli for supplying materials. We are also grateful to Younes Anini and Christine Leroy (INSERM U426) for help with the lysosomal acidification studies.

    FOOTNOTES

* This work was supported by institutional funding from INSERM and by a grant from the Association Vaincre les Maladies Lysosomales.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Marie Curie Fellow of the European Community. To whom correspondence should be addressed: INSERM U410, 16 rue Henri Huchard 75018 Paris, France. Tel.: 33 1 4485 6134; Fax: 33 1 4228 8765; E-mail: moore{at}bichat.inserm.fr.

    ABBREVIATIONS

The abbreviations used are: free OS, free oligosaccharide(s); [3H]free OS, a mixture of metabolically radiolabeled free OS; [3H] Man5GlcNAc, purified metabolically radiolabeled free Man5GlcNAc; CCM A, concanamycin A; NEM, N-ethylmaleimide; AMP-PCP, adenylyl-(beta ,gamma -methylene)diphosphonate; AMP-PNP, 5'-adenylyl-beta ,gamma -imidodiphosphate; ATPgamma S, adenosine 5'-O-(3-thiotriphosphate); ER, endoplasmic reticulum; FITC, fluorescein isothiocyanate; SH, HEPES-buffered sucrose.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Anumula, K. R., and Spiro, R. G. (1983) J. Biol. Chem. 258, 15274-15282[Abstract/Free Full Text]
  2. Cacan, R., Cecchelli, R., and Verbert, A. (1987) Eur. J. Biochem. 166, 469-474[Abstract]
  3. Spiro, M. J., and Spiro, R. G. (1991) J. Biol. Chem. 266, 5311-5317[Abstract/Free Full Text]
  4. Villers, C., Cacan, R., Mir, A.-M., Labiau, O., and Verbert, A. (1994) Biochem. J. 298, 135-142[Medline] [Order article via Infotrieve]
  5. Cacan, R., and Verbert, A. (1997) Trends Glycosci. Glycotechnol. 9, 365-377
  6. Cacan, R., Lepers, A., Belard, M., and Verbert, A. (1989) Eur. J. Biochem. 185, 173-179[Abstract]
  7. Moore, S. E. H., Bauvy, C., and Codogno, P. (1995) EMBO J. 14, 6034-6042[Abstract]
  8. Moore, S. E. H. (1998) Glycobiology 8, 373-381[Abstract/Free Full Text]
  9. Römisch, K., and Schekman, R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7227-7231[Abstract]
  10. Römisch, K., and Ali, B. R. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 6730-6734[Abstract/Free Full Text]
  11. Pilon, M., Schekman, R., and Römisch, K. (1997) EMBO J. 16, 4540-4548[Abstract/Free Full Text]
  12. Wiertz, E. J. H. J., Tortorella, D., Bogyo, M., Yu, J., Mothes, W., Jones, T. R., Rapoport, T. A., and Ploegh, H. L. (1996) Nature 384, 432-438[CrossRef][Medline] [Order article via Infotrieve]
  13. Suzuki, T., Kitajima, K., Inoue, S., and Inoue, Y. (1994) Glycoconj. J. 11, 469-476[Medline] [Order article via Infotrieve]
  14. Suzuki, T., Yan, Q., and Lennarz, W. J. (1998) J. Biol. Chem. 273, 10083-10086[Free Full Text]
  15. Cacan, R., Dengrement, C., Labiau, O., Kmiécik, D., Mir, A.-M., and Verbert, A. (1996) Biochem. J. 313, 597-602[Medline] [Order article via Infotrieve]
  16. Moore, S. E. H., and Spiro, R. G. (1994) J. Biol. Chem. 269, 12715-12721[Abstract/Free Full Text]
  17. Saint-Pol, A., Bauvy, C., Codogno, P., and Moore, S. E. H. (1997) J. Cell Biol. 136, 45-59[Abstract/Free Full Text]
  18. Pierce, R. J., Spik, G., and Montreuil, J. (1979) Biochem. J. 180, 673-676[Medline] [Order article via Infotrieve]
  19. Haeuw, J.-F., Strecker, G., Wieruszeski, J.-M., Montreuil, J., and Michalski, J.-C. (1991) Eur. J. Biochem. 1257-1268
  20. Oku, H., and Hase, S. (1991) J. Biochem. (Tokyo) 110, 982-989[Abstract]
  21. Shoup, V., and Touster, O. (1976) J. Biol. Chem. 251, 3845-3852[Abstract]
  22. Yamashita, K., Tachibana, Y., Mihara, K., Okada, S., Yabuuchi, H., and Kobata, A. (1980) J. Biol. Chem. 255, 5126-5133[Abstract/Free Full Text]
  23. Strecker, G., Fournet, B., Bouquelet, S., Montreuil, J., Dhondt, J. L., and Farriaux, J.-P. (1976) Biochimie 58, 579-586[Medline] [Order article via Infotrieve]
  24. Smythe, E. (1996) in Biology of the Lysosome (Lloyd, J. B., and Mason, R. W., eds), Vol. 27, pp. 51-92, Plenum Press, New York
  25. Dunn, W. A., Jr. (1994) Trends Cell Biol. 4, 139-143[CrossRef]
  26. Cuervo, A.-M., and Dice, J. F. (1996) Science 273, 501-503[Abstract]
  27. Pisoni, R. L., Acker, T. L., Lisowski, K. M., Lemons, R. M., and Theone, J. G. (1990) J. Cell Biol. 110, 327-335[Abstract]
  28. Barrueco, J. R., and Sirotnak, F. M. (1991) J. Biol. Chem. 266, 11732-11737[Abstract/Free Full Text]
  29. Moore, S. E. H., and Spiro, R. G. (1990) J. Biol. Chem. 265, 13104-13112[Abstract/Free Full Text]
  30. Belard, M., Cacan, R., and Verbert, A. (1988) Biochem. J. 255, 235-242[Medline] [Order article via Infotrieve]
  31. Neefjes, J. J., Momburg, F., and Hammerling, G. J. (1993) Science 261, 769-771[Medline] [Order article via Infotrieve]
  32. Rijnboutt, S., Stoorvogel, W., Geuze, H. J., and Strous, G. J. (1992) J. Biol. Chem. 267, 15665-15672[Abstract/Free Full Text]
  33. Ohkuma, S., Moriyama, Y., and Takano, T. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2758-2762[Abstract]
  34. Opheim, D. J., and Touster, O. (1977) J. Biol. Chem. 252, 739-743[Abstract]
  35. Trowbridge, I. S., and Hyman, R. (1979) Cell 17, 503-508[Medline] [Order article via Infotrieve]
  36. Chapman, A., Trowbridge, I. S., Hyman, R., and Kornfeld, S. (1979) Cell 17, 509-515[Medline] [Order article via Infotrieve]
  37. Chapman, A., Fujimoto, K., and Kornfeld, S. (1980) J. Biol. Chem. 255, 4441-4446[Free Full Text]
  38. Jonas, A. J., Speller, R. J., Conrad, P. B., and Dubinsky, W. P. (1989) J. Biol. Chem. 264, 4953-4956[Abstract/Free Full Text]
  39. Mancini, G. M. S., de Jonge, H. R., Galjaard, H., and Verheijen, F. W. (1989) J. Biol. Chem. 264, 15247-15254[Abstract/Free Full Text]
  40. Lloyd, J. B. (1996) in Biology of the Lysosome (Lloyd, J. B., and Mason, R. W., eds), Vol. 27, pp. 361-383, Plenum Press, New York
  41. Baur, H., and Heldt, H. W. (1977) Eur. J. Biochem. 74, 397-403[Abstract]
  42. Mancini, G. M. S., Beerens, C. E. M. T., and Verheijen, F. W. (1990) J. Biol. Chem. 265, 12380-12387[Abstract/Free Full Text]
  43. Lee, W.-S., Kanai, Y., Wells, R. G., and Hediger, M. A. (1994) J. Biol. Chem. 269, 12032-12039[Abstract/Free Full Text]
  44. Ambudkar, S. V., Lelong, I. H., Zhang, J., Cardarelli, C. O., Gottesman, M. M., and Pastan, I. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8472-8476[Abstract]
  45. Al-Awqati. (1986) Annu. Rev. Cell Biol. 2, 179-199[CrossRef]
  46. Woo, J.-T., Shinohara, C., Sakai, K., Hasumi, K., and Endo, A. (1992) J. Antibiot. (Tokyo) 45, 1108-1116[Medline] [Order article via Infotrieve]
  47. Fohr, K. J., Scott, J., Ahnert-Hilger, G., and Gratzl, M. (1989) Biochem. J. 262, 83-89[Medline] [Order article via Infotrieve]
  48. Beintema, J. J. (1994) FEBS Lett. 350, 159-163[CrossRef][Medline] [Order article via Infotrieve]
  49. Allen, A. K., Neuberger, A., and Sharon, N. (1973) Biochem. J. 131, 155-162[Medline] [Order article via Infotrieve]
  50. Lee, R. T., Gabius, H.-J., and Lee, Y. C. (1998) Glycoconj. J. 15, 649-655[CrossRef][Medline] [Order article via Infotrieve]
  51. Semino, C., Specht, C. A., Raimondi, A., and Robbins, P. W. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4548-4553[Abstract/Free Full Text]
  52. Varki, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4523-4525[Abstract/Free Full Text]
  53. Tietze, F., Seppala, R., Renlund, N., Hopwood, J. J., Harper, G. S., Thomas, G. H., and Gahl, W. (1989) J. Biol. Chem. 264, 15316-15322[Abstract/Free Full Text]
  54. Chou, H.-F., Passage, M., and Jonas, A. J. (1997) Biochem. J. 327, 781-786[Medline] [Order article via Infotrieve]
  55. Kato, T., Hatanaka, K., Mega, T., and Hase, S. (1997) J. Biochem. (Tokyo) 122, 1167-1173[Abstract]
  56. Patel, S., and Latterich, M. (1998) Trends Cell Biol. 8, 65-71 [CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.